The results of this study support the hypothesis that ADAMTS13 activity levels and anti-ADAMTS13 antibodies are useful prognostic markers for gravidic complications (TTP recurrence and miscarriage) in women with previous acquired TTP. This evidence concerns the gene ADAMTS13 and thrombotic thrombocytopenic purpura.